# China NMPA Product Recall - Trauma surgical instruments

Source: https://www.globalkeysolutions.net/records/china_product_recall/synthes-gmbh/b094fa7c-dd13-4b7d-8aaf-93bdf748a4cd/
Source feed: China

> China NMPA product recall for Trauma surgical instruments by Synthes GmbH published April 08, 2014. Recall level: . The National Medical Products Administration (NMPA) issued a recall notice regarding trauma surgical

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Synthes GmbH of Switzerland recalls surgical instruments for trauma surgery.
- Company Name: Synthes GmbH
- Publication Date: 2014-04-08
- Product Name: Trauma surgical instruments
- Recall Reason: The instrument of a specific model and batch number was incorrectly etched and labeled with model number 399.240. The correct model number should be 399.220.
- Discovering Company: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: Synthes GmbH
- Summary: The National Medical Products Administration (NMPA) issued a recall notice regarding trauma surgical instruments manufactured by Synthes GmbH, Switzerland. This voluntary recall was reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. on March 27, 2014, with the NMPA publication date of April 8, 2014. The core issue identified was incorrect product labeling: a specific model of surgical device was mis-etched and mislabeled as model 399.240, when the accurate model designation should have been 399.220. These instruments are specialized auxiliary tools designed for SYNTHES trauma implants, facilitating the implantation and removal of various bone implants. Under the NMPA's regulatory framework, the manufacturer confirmed that no affected products were imported into or sold within the Chinese market. As a result, Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. indicated that no additional corrective actions, such as detailed investigations or implementation plans, were required in China. Nevertheless, provincial, autonomous region, and municipal food and drug administrations were directed to reinforce their supervision and management over similar medical devices, ensuring continued vigilance despite the absence of affected units in the domestic market. The primary impact of this recall was in regions such as the USA.

Company: https://www.globalkeysolutions.net/companies/synthes-gmbh/77a06946-ba7a-4bf2-916a-600eabfb0ce7/